Bay Harbor Wealth Management’s Moderna MRNA Stock Holding History

Bay Harbor Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.27K	Buy	61 +13	+27%	+$673	﹤0.01%	456
2026 Q1	$2.44K	Buy	48 +40	+500%	+$1.87K	﹤0.01%	515
2025 Q4	$235	Buy	8 +3	+60%	+$82	﹤0.01%	1087
2025 Q3	$129	Buy	5 +2	+67%	+$56	﹤0.01%	1131
2025 Q2	$82	Buy	+3	New	+$79	﹤0.01%	1138
2021 Q1	–	Sell	-62	Closed	-$6K	–	353
2020 Q4	$6K	Buy	+62	New	+$6.27K	﹤0.01%	270
2020 Q2	–	Sell	-81	Closed	-$2K	–	394
2020 Q1	$2K	Buy	+81	New	+$1.86K	﹤0.01%	269

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Bay Harbor Wealth Management's MRNA Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Moderna (MRNA) stake by 27% in Q2 2026, buying an estimated $673 and bringing the position to 61 shares worth $4.27K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

Bay Harbor Wealth Management first reported a position in MRNA in Q1 2020 and has held it in 7 quarters since. The position peaked at $6K in Q4 2020. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Bay Harbor Wealth Management held 61 shares of Moderna worth $4.27K as of Q2 2026.
Bay Harbor Wealth Management bought 13 Moderna shares in Q2 2026, an estimated $673.
Moderna made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #456 holding.
Bay Harbor Wealth Management first reported a position in Moderna in Q1 2020 and has held it in 7 quarters since.
Bay Harbor Wealth Management's Moderna position peaked at $6K in Q4 2020.
782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.